3.3.4 Targeted RNA Sequencing Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Illumina
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Targeted RNA Sequencing Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Omicia
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Targeted RNA Sequencing Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Roche Holdings
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Targeted RNA Sequencing Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Inc. Qiagen Diagnostics
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Targeted RNA Sequencing Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Zoetis Genetics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Targeted RNA Sequencing Revenue (Value) (2012-2017)
3.8.5 Recent Developments
4 Global Targeted RNA Sequencing Market Size by Type and Application (2012-2017)
4.1 Global Targeted RNA Sequencing Market Size by Type (2012-2017)
4.2 Global Targeted RNA Sequencing Market Size by Application (2012-2017)
4.3 Potential Application of Targeted RNA Sequencing in Future
4.4 Top Consumer/End Users of Targeted RNA Sequencing
5 United States Targeted RNA Sequencing Development Status and Outlook
5.1 United States Targeted RNA Sequencing Market Size (2012-2017)
5.2 United States Targeted RNA Sequencing Market Size and Market Share by Players (2016 and
2017)
6 EU Targeted RNA Sequencing Development Status and Outlook
6.1 EU Targeted RNA Sequencing Market Size (2012-2017)
6.2 EU Targeted RNA Sequencing Market Size and Market Share by Players (2016 and 2017)
7 Japan Targeted RNA Sequencing Development Status and Outlook
7.1 Japan Targeted RNA Sequencing Market Size (2012-2017)